Overview

A Study of Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD)

Status:
Active, not recruiting
Trial end date:
2023-04-28
Target enrollment:
Participant gender:
Summary
The purpose of this study is to learn about health care use, costs, and clinical outcomes over time for amyloid positive participants with early stages of AD in the United States. This study is for research purposes only, and is not intended to treat any medical condition. No study therapy(ies) for AD will be administered.
Phase:
N/A
Details
Lead Sponsor:
Eli Lilly and Company